Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Weekly Inotuzumab Ozogamicin (InO) In Adult Patients With Relapsed Or Refractory CD22-Positive Acute Lymphoblastic Leukemia (ALL)

Daniel J. DeAngelo, MD, Ph.D, Wendy Stock, M.D., Andrei R. Shustov, MD, Michaela Liedtke, MD, Charles A. Schiffer, MD, Revathi Ananthakrishnan, Joseph P. Boni, PhD, Kenneth Luu, Katherine Liau, Erik Vandendries, MD, Anjali S. Advani, MD

Blood (2013) 122 (21): 3906.

https://doi.org/10.1182/blood.V122.21.3906.3906

Published: 2013

Journal Articles

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Uma Borate, MD, Amir T. Fathi, MD, Bijal D. Shah, MD, Daniel J. DeAngelo, MD, Ph.D, Lewis B. Silverman, MD, Todd Michael Cooper, Tina M. Albertson, MD, PhD, Megan M. O'Meara, MD, Larissa Sandalic, MS, Faith Stevison, MS, Robert Chen, MD

Blood (2013) 122 (21): 1437.

https://doi.org/10.1182/blood.V122.21.1437.1437

Published: 2013

Journal Articles

MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study

Daniel J. DeAngelo, MD, Ph.D, Harry P Erba, MD, Michael B Maris, MD, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Faiz Anwer, MD, Jessica K Altman, MD, Zhaowei Hua, Ph.D, Stephen J Blakemore, Ph.D, Hélène Faessel, Ph.D, Bruce J Dezube, MD, Bruno C Medeiros, MD

Blood (2013) 122 (21): 1443.

https://doi.org/10.1182/blood.V122.21.1443.1443

Published: 2013

Journal Articles

HSP90 Inhibition Has Potent Activity Against T-Cell Acute Lymphoblastic Leukemia (T-ALL) Through Degradation Of TYK2 Kinase

Koshi Akahane, Takaomi Sanda, PhD, Marc R. Mansour, MD PhD FRCPath, Julia Etchin, PhD, Ng Cherry, David M. Weinstock, MD, Anthony Letai, MD, PhD, Daniel J. DeAngelo, MD, Ph.D, A. Thomas Look, MD

Blood (2013) 122 (21): 2528.

https://doi.org/10.1182/blood.V122.21.2528.2528

Published: 2013

Journal Articles

Aberrant Splicing In Patients With AML Is Associated With Over- Expression Of Specific Splicing Factors

Sophia Adamia, PhD, Christian Bach, Ph.D., Patrick M Pilarski, Martha Wadleigh, MD, David P. Steensma, MD, Gabriela Motyckova, MD, PhD, Daniel J. DeAngelo, MD, Ph.D, Richard M. Stone, MD, Daniel G. Tenen, MD, James D. Griffin, MD

Blood (2013) 122 (21): 3749.

https://doi.org/10.1182/blood.V122.21.3749.3749

Published: 2013

Journal Articles

The Safety and Adherence To Prophylactic Anticoagulation During Induction Chemotherapy In Adults With Acute Lymphoblastic Leukemia

Rachael F. Grace, MD, Kristen E. Stevenson, MS, Donna S. Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD, Daniel J. DeAngelo, MD, Ph.D, Jean M. Connors, MD

Blood (2013) 122 (21): 3867.

https://doi.org/10.1182/blood.V122.21.3867.3867

Published: 2013

Journal Articles

Targeting Oncogenic Interleukein-7 Receptor Signaling With N-Acetylcysteine In T-Cell Acute Lymphoblastic Leukemia

Marc R. Mansour, MD PhD FRCPath, Casie Reed, Amy Eisenberg, Jen-Chieh Tseng, PhD, Akinori Yoda, PhD, Scott J Rodig, MD, PhD, Daniel J. DeAngelo, MD, Ph.D, Stephen E. Sallan, MD, David M. Weinstock, MD, Shai Izraeli, MD, Andrew L Kung, MD, PhD, Alex Kentsis, MD, PhD, Thomas Look, MD

Blood (2013) 122 (21): 2535.

https://doi.org/10.1182/blood.V122.21.2535.2535

Published: 2013

Journal Articles

BH3 Profiling Predicts On-Target Cell Death Due To Selective Inhibition Of BCL-2 By ABT-199 In Acute Myelogenous Leukemia

Leah Hogdal, Daniel J. DeAngelo, MD, Ph.D, Richard M. Stone, MD, Verena I. Gaidzik, MD, Donna Bucci, Konstanze Döhner, MD, Guido Marcucci, MD, Jeremy Ryan, SM, Anthony Letai, MD, PhD

Blood (2013) 122 (21): 238.

https://doi.org/10.1182/blood.V122.21.238.238

Published: 2013

NARROW

Weekly Inotuzumab Ozogamicin (InO) In Adult Patients With Relapsed Or Refractory CD22-Positive Acute Lymphoblastic Leukemia (ALL)

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study

HSP90 Inhibition Has Potent Activity Against T-Cell Acute Lymphoblastic Leukemia (T-ALL) Through Degradation Of TYK2 Kinase

Aberrant Splicing In Patients With AML Is Associated With Over- Expression Of Specific Splicing Factors

The Safety and Adherence To Prophylactic Anticoagulation During Induction Chemotherapy In Adults With Acute Lymphoblastic Leukemia

Targeting Oncogenic Interleukein-7 Receptor Signaling With N-Acetylcysteine In T-Cell Acute Lymphoblastic Leukemia

BH3 Profiling Predicts On-Target Cell Death Due To Selective Inhibition Of BCL-2 By ABT-199 In Acute Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only